bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $12.18 million. The enterprise value is $4.64 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 4.49 million shares outstanding. The number of shares has increased by 325.83% in one year.
| Current Share Class | 4.49M |
| Shares Outstanding | 4.49M |
| Shares Change (YoY) | +325.83% |
| Shares Change (QoQ) | +319.24% |
| Owned by Insiders (%) | 5.07% |
| Owned by Institutions (%) | 3.95% |
| Float | 4.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.61 |
| Forward PS | 1.91 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.60 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -238.27 |
Financial Efficiency
Return on equity (ROE) is -301.83% and return on invested capital (ROIC) is -105.37%.
| Return on Equity (ROE) | -301.83% |
| Return on Assets (ROA) | -75.63% |
| Return on Invested Capital (ROIC) | -105.37% |
| Return on Capital Employed (ROCE) | -131.26% |
| Weighted Average Cost of Capital (WACC) | 0.11% |
| Revenue Per Employee | $108,105 |
| Profits Per Employee | -$261,575 |
| Employee Count | 57 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 104.16 |
Taxes
In the past 12 months, BIAF has paid $44,042 in taxes.
| Income Tax | 44,042 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.83% in the last 52 weeks. The beta is -0.81, so BIAF's price volatility has been lower than the market average.
| Beta (5Y) | -0.81 |
| 52-Week Price Change | -82.83% |
| 50-Day Moving Average | 2.43 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 46.34 |
| Average Volume (20 Days) | 1,137,102 |
Short Selling Information
The latest short interest is 515,756, so 11.48% of the outstanding shares have been sold short.
| Short Interest | 515,756 |
| Short Previous Month | 542,083 |
| Short % of Shares Out | 11.48% |
| Short % of Float | 12.09% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, BIAF had revenue of $6.16 million and -$14.91 million in losses. Loss per share was -$8.66.
| Revenue | 6.16M |
| Gross Profit | 1.94M |
| Operating Income | -10.57M |
| Pretax Income | -14.87M |
| Net Income | -14.91M |
| EBITDA | -10.07M |
| EBIT | -10.57M |
| Loss Per Share | -$8.66 |
Full Income StatementBalance Sheet
The company has $6.45 million in cash and $1.16 million in debt, giving a net cash position of $5.29 million or $1.18 per share.
| Cash & Cash Equivalents | 6.45M |
| Total Debt | 1.16M |
| Net Cash | 5.29M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 7.28M |
| Book Value Per Share | 1.62 |
| Working Capital | 4.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.33 million and capital expenditures -$60,568, giving a free cash flow of -$9.39 million.
| Operating Cash Flow | -9.33M |
| Capital Expenditures | -60,568 |
| Depreciation & Amortization | 504,836 |
| Net Borrowing | -369,721 |
| Free Cash Flow | -9.39M |
| FCF Per Share | -$2.09 |
Full Cash Flow StatementMargins
Gross margin is 31.40%, with operating and profit margins of -171.58% and -241.96%.
| Gross Margin | 31.40% |
| Operating Margin | -171.58% |
| Pretax Margin | -241.25% |
| Profit Margin | -241.96% |
| EBITDA Margin | -163.38% |
| EBIT Margin | -171.58% |
| FCF Margin | n/a |